From: "Aaron Atkins" <aaron.atkins@hhsys.org>
To: "Pharmacists" <grp_allpharm@hhsys.org>
Sent: Thursday, July 14, 2022 1:56:26 PM
Subject: Additional Placeholder Orders: Aminoglycosides

Per request received to PharmIT, additional "HOLD PER PKS" formulary items
have been created for gentamicin, tobramycin, and amikacin.  Forwarding
previous notification/education on this for reference related to the initial
use of warfarin and vancomycin.

Please let us know if you have any questions or encounter any issues.

Aaron B. Atkins, Pharm.D., BCPS
Clinical Pharmacist, Informatics Lead
Huntsville Hospital
(256)265-3276


-----Original Message-----
From: Gregg Knowles [mailto:gregg.knowles@hhsys.org]
Sent: Tuesday, May 26, 2020 12:01 PM
To: Pharmacists
Subject: Placeholder Orders for PKS managed warfarin and vancomycin

To All,

On Tuesday, May 26, a formal, unified process for creating placeholder
orders will go live in Cerner.  This applies only to PKS managed warfarin
and vancomycin, but could be expanded at a later date.  The process results
in a 'dummy' order on the profile stating 'Warfarin HOLD PER PKS' or
likewise for vanco.  Please review the Placeholder Order tip sheet attached,
and implement going forward.  It is expected all RPhs managing warfarin and
vanco will use the placeholder order process when appropriate from this time
forward.  Advantages to using a placeholder order include:

1. MD made aware PKS is continuing to follow/manage the drug 2. Order is
recognized by Sentri, which aids with PKS reconciliation 3. Order performs
drug interaction checking on the profile

If an MD discontinues the placeholder order, that can be interpreted two
different ways, i.e. the drug is being discontinued, or the hold is being
discontinued.  Pharmacy does not interpret.  If there is no clear
documentation of the MDs intent with discontinuing the placeholder order,
the MD must be called.  Hopefully this will be a rare scenario.

Let me know of any issues.

Gregg